Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Cancer|December 12, 2007
Preclinical modeling of endocrine response and resistance: focus on aromatase inhibitorsLuciana F Macedo, Gauri Sabnis, Angela BrodieFuture Oncology (London, England)|February 25, 2014
mTOR inhibitors: changing landscape of endocrine-resistant breast cancerSaranya Chumsri, Gauri Sabnis, Katherine Tkaczuk, et al.Cancer Research|May 4, 2005
The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivationGauri J Sabnis, Danijela Jelovac, Brian Long, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogensGauri Sabnis, Olga Goloubeva, Danijela Jelovac, et al.The Journal of Steroid Biochemistry and Molecular Biology|February 22, 2011
Aromatase, aromatase inhibitors, and breast cancerSaranya Chumsri, Timothy Howes, Ting Bao, et al.Cancer Research|February 5, 2009
Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogenGauri Sabnis, Adam Schayowitz, Olga Goloubeva, et al.Expert Review of Anticancer Therapy|February 25, 2014
Advances in mechanisms of resistance to aromatase inhibitorsSaranya Chumsri, Amanda Schech, Chakkapong Chakkabat, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 24, 2004
Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detectionChunyu Wu, Vincent Njar, Angela Brodie, et al.Molecular Cancer Therapeutics|January 8, 2010
Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatmentGauri Sabnis, Olga Goloubeva, Rabia Gilani, et al.Breast Cancer Research and Treatment|March 20, 2013
Effect of selumetinib on the growth of anastrozole-resistant tumorsGauri J Sabnis, Armina Kazi, Olga Golubeva, et al.Pageof 4